Equities

Kyorin Pharmaceutical Co Ltd

Kyorin Pharmaceutical Co Ltd

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue119,532113,270105,534
OPERATING EXPENSES
Cost of revenue total68,12463,10256,093
Selling, general and admin. expenses, total37,37534,14035,536
Depreciation/amortization8.004.004.00
Unusual expense(income)486(410)320
Other operating expenses, total1.002.001.00
Total operating expense114,013107,741100,851
Operating income5,5195,5294,683
Other, net11623198
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes7,0196,9065,216
Provision for income taxes1,6962,1821,284
Net income after taxes5,3234,7243,932
Minority interest------
Net income before extra. Items5,3234,7243,932
Total extraordinary items------
Net income5,3234,7243,932
Inc.avail. to common excl. extra. Items5,3224,7233,932
Inc.avail. to common incl. extra. Items5,3224,7233,932
EPS RECONCILIATION
Basic/primary weighted average shares575757
Basic/primary eps excl. extra items938269
Basic/primary eps incl. extra items938269
Dilution adjustment------
Diluted weighted average shares575757
Diluted eps excl. extra items938269
Diluted eps incl. extra items938269
COMMON STOCK DIVIDENDS
DPS - common stock primary issue525252
Gross dividend - common stock3,0223,0223,022
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental666666
SUPPLEMENTAL INCOME
Depreciation, supplemental4,2903,8403,714
Total special items576(395)352
NORMALISED INCOME
Normalized income before taxes7,5956,5115,568
Effect of special items on income taxes139(125)87
Income tax excluding impact of special items1,8352,0571,371
Normalized income after tax5,7604,4544,197
Normalized income avail. to common5,7594,4534,197
Basic normalized EPS1007873
Diluted normalized EPS1007873
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.